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ABSTRACT:
An original method to extract and detect barbiturates, specifically secobarbital, in
hair by enzyme-linked immunosorbent assay (ELISA), has been developed. Drug-free
hair specimens were fortified with an exaggerated amount of secobarbital to produce a
homogeneous, true positive sample to be utilized to test the drug extraction efficiency
from hair. Drug extraction using hair extraction buffer (HEB) from Immunalysis was
compared to a base digestion using 1M NaOH. After LCMS/MS analysis, HEB
extraction was deemed a successful method for extracting barbiturates from hair. Using
this method, the Barbiturates Direct ELISA Kit from Immunalysis was evaluated for its
potential use in the detection of barbiturates in hair specimens. After thorough analysis, it
appears the kit is more than suitable as a screening assay due to its sensitivity and
reproducibility.
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I. INTRODUCTION:
1. Barbiturates Background
The worldwide rise in prescription drug misuse has not gone unnoticed. Over the
last 15 years, misuse has been reflected in increased emergency room visits, treatments
for addiction, and deaths due to overdose (NIDA, 2016). Overdose deaths alone have
increased from almost 10,000 in 2001 to more than twice that amount at 25,000 in 2014
(NIDA, 2016). There are three main culprits of misused prescription drugs, one of which
are central nervous system depressants. This category of drugs includes substances that
can slow brain activity (i.e. tranquilizers, sedatives, and hypnotics). An example of which
are barbiturates. In 2011, the Substance Abuse and Mental Health Services
Administration (SAMHSA) reported that approximately 18,000 emergency calls
involving the use of non-prescribed barbiturates took place in the United States
(SAMHSA, 2013). Additionally, a study done in the UK from 1983-1999 found that for
every million barbiturate prescriptions, 146.2 lead to fatal toxicities (Buckley, &
McManus, 2004). Because of its higher risk in overdose fatalities, barbiturates have
mostly been replaced by benzodiazepines, but they are still prescribed today.
Barbiturates were introduced into medicine in 1903 after the discovery of its
sedative-hypnotic action; dominating the market for the first half of the 20th century.
Today, there are numerous variants available, all of which are derivatives of barbituric
acid – typically differing at the C5 position in structure. These modifications affect the
compound’s lipid solubility and, thus, duration of activity (Levine, 2013). For example,
secobarbital contains an allyl and 1-methylbutyl group at the C5 position which makes it
more lipid soluble and potent but, also, short acting. As stated above, this drug class is a

2
central nervous system (CNS) depressant that has been primarily prescribed as sedative
hypnotics, anticonvulsants, and for migraine therapy (Levine, 2013). Barbiturates are
most commonly administered orally, but have been known to be given intravenously or
intramuscularly. They are rapidly absorbed and distribution occurs throughout the major
tissues of the body (Silberstein, & McCrory, 2001). Depending on the duration of action,
barbiturates are either almost completely metabolized (short-acting) by the liver or
remain mostly unchanged (long-acting) (Silberstein, & McCrory, 2001). They
preferentially suppress polysynaptic neuronal responses primarily by binding to a
chloride ion channel, γ-aminobutyric acid (GABA) A receptor. This, in turn, activates the
receptor, prolonging the opening of the channel and allowing for an influx of chloride
ions (Silberstein, & McCrory, 2001). Although benzodiazepines also interact with the
GABAA receptor, they potentiate different reactions. Barbiturates cause the receptor to
remain open for longer, whereas, benzodiazepines increase the affinity of GABA for the
receptor (Bianchi, Botzolakis, Lagrange, & Macdonanld, 2009). Because of this, the
therapeutic index for barbiturates is low – increasing the likelihood of intoxication and
overdose. Intoxication symptoms include: sluggishness, difficulty thinking, poor memory,
slowed speech and comprehension, impaired judgement, and decreased attention span
(Silberstein, & McCrory, 2001). Although barbiturates can produce tolerance, and result
in dependence and addiction, some are still administered today and should be closely
monitored. Below are three examples of barbiturates, ranging in different durations of
action.
1.1 Secobarbital
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Secobarbital is a short-acting barbiturate with a half-life of 22-29 hours
(Levine, 2013). It is typically used to treat insomnia, or as a sedative before
surgery.
1.2 Butalbital
Butalbital is an intermediate-acting derivative of barbituric acid. Commonly
compounded with aspirin, acetaminophen, and/or caffeine, they are widely
used for the treatment of migraines and tension-type headaches (Silberstein, &
McCrory, 2001). 36% of patients taking prescription medicine for their
headaches, take butalbital-containing analgesic combinations (Ferrari,
Tifaferri, Palazzoli, Verri, Vandelli, Marchesi, Ciccarese, & Licata, 2015).
1.3 Phenobarbital
Phenobarbital is a long-acting barbiturate with limited metabolism and an
elimination half-life of 2-5 days. It is one of the more commonly prescribed
barbiturates today for its use in the treatment of epileptic seizures (Levine,
Roveri, Paranhos, & Yonamine, 2016).

2. Hair Matrix
In recent years, analysis of the hair matrix has gained increasing importance in the
determination of substances of abuse. With hair having the longest window of drug
detection, as compared to the other more classic biological specimens (urine, oral fluid,
and serum, in that order respectively), it has gained popularity of use in forensic cases
and clinical toxicology. Typically, drug detection in hair is from weeks to months, where
as in urine it is from hours to days and in blood, minutes to hours (Levine, 2013). This
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allows for diagnostic information regarding the identity and concentration of drug(s) to
be obtained over an extended period of time. Other advantages to using hair as a matrix
include: its non-invasive collection; and its long and easy storage. With barbiturate
analysis having been previously demonstrated in urine, serum, and oral fluid, this study
established it for hair analysis for use in patient drug monitoring and/or forensic case
work.
Hair is a non-homogeneous fiber; it is solid and durable. It consists of keratinized
cells that form three concentric structures –the cuticle, cortex, and medulla (Figure 1)
(Pragst, & Balikova, 2006).
Figure 1.

Figure 1. Structure and constituents of the human hair shaft.
Each fiber originates from the hair follicle, which resides 3-5 mm below the scalp-dermal
layer and is nourished by a network of capillaries (Pragst, & Balikova, 2006). The cuticle
consists of a thin layer of cells that overlap in a shingle-like fashion and make up the
outside of the hair shaft (Levine, 2013). Beneath the cuticle contains the cortex which
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consists of tightly packed, keratin-filled, microfibrils that make up the cell membrane
complex (Levine, 2013). This part of the hair is the primary diffusion point for
incorporation and diffusion of drugs, with lipophilic drugs being preferentially deposited
(Pragst, & Balikova, 2006). Lastly, the most inner part of the hair structure is the medulla.
Here is where ingested drugs are primarily deposited (Levine, 2013). The life cycle of
human hair consists of three main phases – the anagen phase, catagen phase, and telogen
phase (Levine, 2013). The anagen phase is also known as the growth phase. During this
phase, the hair grows at a rate of about 0.44mm per day (0.38-0.48mm) for men and
0.45mm per day (0.4-0.55mm) for women (Nakahara, 1999). At this rate, drugs within
the hair emerge above the surface about 5-7 days after ingestion (Levine, 2013). The
catagen phase, or transition phase, is when the root end of the hair becomes keratinized
and begins to separate from the bulb (Levine, 2013). After about 4-6weeks, the hair
enters the telogen phase, or resting phase, in which the hair shaft stops growing
completely and can be easily pulled out (Nakahara, 1999).
There are several mechanisms in which drugs can be incorporated into hair. One
of which is through passive diffusion from the blood capillaries into the matrix cells of
the growing hair (Levine, 2013). Another, is via sweat or sebum secretions (Pragst, &
Balikova, 2006). In addition, substances such as smoke and powders can be deposited
from the external environment, making the hair washing step prior to extraction critical
(Nakahara, 1999). Experimental data has also suggested that delayed incorporation can
occur from deep skin compartments during hair shaft formation (Pragst, & Balikova,
2006).
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The mechanism that will predominate is strongly influenced by the structural and
chemical properties of the drug, as well as, the physical and physiological characteristics
of the individual. An example of this is an individual’s hair pigmentation. It has been
shown that pigmented hair had about a 10-fold higher concentration of basic drugs than
that of non-pigmented hair, despite having the same drug concentration in blood (Rothe,
Pragst, Thor, & Hunger, 1997). Additionally, it has been demonstrated that melanin, the
compound responsible for hair pigmentation, has a stronger affinity for basic drugs
(Claffey, Stout, & Ruth, 2001).
For analysis, a sample of hair is taken from the back of the donor’s scalp in a
cosmetically consealable area. This lock is about 1 inch wide by 1-2 strands deep and cut
close to the scalp (Levine, 2013). It is wrapped in foil with the cut, root-end protruding
and stored in an envelope in a cool dry place for as long as 5 years. Generally,
approximately 4cm (or 1½ inches) of collected hair is cut from the root end for analysis.
This length of hair reflects approximately 90 days (Levine, 2013). The sample of hair is
then typically either cut into smaller segments, or pulverized in a ball mill, allowing for
greater surface area to optimize the extraction process. Prior to the extraction process, the
hair is weighed into aliquots (typically ranging from 10-50mg, depending on the assay)
and then washed. Because hair is exposed to the outside environment, it may become
contaminated with drugs via vapor or direct contact and, thus, an efficient wash
procedure is necessary. The challenge in any wash procedure is to remove as much drug
present on the surface of the hair while keeping the internalized drug within the hair for
analysis. There are many wash techniques implemented today, but in general, it involves
an incubation with an organic solvent (such as dichloromethane, isopropanol, or
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methanol), followed by an additional one or two washes with an aqueous solvent (such as
sodium phosphate buffer) (Levine, 2013). The use of an organic solvent removes any
external contaminants residing on the exterior of the hair, while the aqueous solution
causes the hair to swell – both allowing for the removal of any drugs that may have
diffused from the exterior to the cortex of the hair. Similar to the wash procedure, there is
no designated method for the extraction of drugs from hair. Typical procedures incubate
the hair in an organic solvent (most commonly methanol) for extended periods of time,
ranging from 5-18 hours (Pragst, & Balikova, 2006). However, studies have shown that
basic drugs are well extracted using either aqueous acids or phosphate buffer (Moeller,
Fey, & Wennig, 1993; Kintz, & Mangin, 1995). Whereas, compounds that are stable
under alkaline conditions, typically extract well using a 1M NaOH digestion for much
shorter periods of time. In this study, a commercially available hair extraction buffer
(HEB) was utilized. To determine that the HEB was the optimal extraction technique for
barbiturates, it was tested against 1M NaOH dissolution using in-house prepared fortified
hair samples. Although some laboratories use authentic hair, fortified hair ensures
homogeneity and has been used in proficiency testing programs since 1990 (Lee, Park,
Han, Choe, Lim, & Chung, 2008). Because it has been shown that DMSO is a useful
penetrating carrier for absorption enhancement of the compound of interest into the hair,
a 50% solution of DMSO ± 0.02M HCl was utilized in the fortification process (Welch,
Sniegoski, Allgood, & Habram, 1993; Welch, Sniegoski, & Tai, 2003; Lee et al., 2008).

3. Screening
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The first hair analyses for drugs were performed by radioimmunoassay (RIA)
(Pragst, & Balikova, 2006). Today there are more options readily available –like the
enzyme-linked immunosorbent assay (ELISA), for example. The ELISA is an excellent
screening technique for hair drug testing due to its sensitivity and ability to detect low
levels. However, these assays are not typically validated for use in hair and thus must be
before use. The principle design behind an enzyme immuoassay is the antigen-antibody
interaction. A host organism is injected with a drug/compound bound to a carrier protein
to induce an immune response (Levine, 2013). As a result, antibodies against the target
analyte are produced and subsequently collected for use in commercial screening kits.
Because the antibodies produced have different epitopes towards the target, crossreactivity between similarly structured compounds occurs. The antibodies are then fixed
to a 96-well plate, where sample and enzyme-conjugated target drug compete for
antibody binding sites (Levine, 2013). The enzyme conjugate is typically horseradish
peroxidase (HRP). Following the addition of a substrate, 3,3’,5,5’-tetramethylbenzidine
(TMB), any bound HRP-conjugated target drug will oxidize the chromogenic substrate
into a blue colored product. A Stop Solution containing a dilute HCl solution is then
added to quench the reaction and, ultimately, changing the color reaction from blue to
yellow. In the event that a sample is positive, very little HRP-conjugated drug will bind
causing a slight color change. Whereas, a negative sample will produce a greater color
change. The absorbance is measured spectrophotometrically. In this study, the
Barbiturate Direct ELISA Kit from Immunalysis was validated for the presumptive
screening of barbiturates in hair. The target analyte is secobarbital, but the ELISA has
crossreactivity capabilities.
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4. LCMS/MS
A liquid chromatography tandem mass spectrometry system (LCMS/MS) is
an instrument that allows for the separation, detection, and identification of compounds
(Skoog, Holler, & Crouch, 2007). Liquid chromatography separates the sample
components while bringing them to the mass spectrometer, where the compounds are
ionized, detected, and identified (Skoog et al., 2007). The use of a calibration curve made
up of known concentrations of the target analyte allows for its quantification. A
deuterated form of the analyte is used to control for extraction, and LCMS/MS injection
and ionization variability.
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II. MATERIALS:
1. Chemicals and Reagents:
Secobarbital and secobarbital-d5 were purchased from Cerilliant (Round Rock,
TX). The Barbiturates Direct ELISA kit, hair extraction buffer (HEB), bovine serum
albumin (BSA), and neutralizing buffer (NEB) were obtained from Immunalysis
Corporation (Pomona, CA). All HPLC grade solvents and ACS grade chemicals were
purchased from VWR (Radnor, PA). All consumables were purchased from VWR
(Radnor, PA) unless otherwise noted. Trace-B mixed-mode solid phase extraction (SPE)
columns, autosampler vials, and autosampler snap caps were purchased from SPEware
Corporation (Baldwin Park, CA).

2. Apparatus:
The Tecan-fre (used to pipette all calibrators, controls, and samples into the
microplate wells), the Columbus Plus plate washer, and the Sunrise® Basic Tecan plate
reader were all purchased from Tecan (San Jose, CA). Magellan software was used to
analyze the OD readings. The CEREX ALD III 48 used to dispense solvents and
solutions during the solid phase extraction, was purchased from SPEware (Baldwin Park,
CA). All confirmational analyses were performed using a liquid chromatography/tandem
mass spectroscopy system (LCMS/MS). The LC system used was an Agilent 1290
Infinity Series, coupled to an Agilent 6460 triple quadropole tandem mass analyzer
equipped with a jet stream electrospray ionization source. The analytical columns used
were Zorbax® Eclipse Plus C18 columns with a 2.1 mm diameter, 50 mm length, and 1.8
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µm particle size (Agilent Technologies, Santa Clara, CA). The mobile phases used were
0.2% acetic acid and acetonitrile.

3. Samples:
Drug free hair was voluntarily donated from the author and stored in a sealed bag
at room temperature. Prior to use in the validation process, the hair was verified to be
negative.
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III. METHODS:
1. Sample Preparation:
The hair was cut into 1-2 cm sections and 10 mg aliquots were placed into
13x100mm glass tubes. Hair samples were then washed with dichloromethane, isopropyl
alcohol, and methanol to remove external contamination. 1 mL of each solvent was added,
vortexed for 5 minutes, decanted and evaporated with a gentle stream of nitrogen at 65°C.

2. Calibration Curve for Screen:
Eight aliquots of 10 mg of washed negative hair was prepared. To this, different
concentrations of secobarbital was added. Concentrations of 0 pg/mg (negative control),
250 pg/mg (low positive control), 500 pg/mg (calibrator cutoff), and 1000 pg/mg (high
positive control) of secobarbital were spiked in duplicate.

3. Drug Extraction from Hair:
Calibrators, quality controls, and unknown samples were subjected to 550 μL of
HEB. The samples were then incubated at 75°C for 2 hours, followed by neutralization
using 50 μL of NEB. After centrifugation at 4,200 rpm for 10 min, 200 μL of supernatant
was transferred to another tube and diluted with 400 μL of BSA and vortexed.

4. ELISA:
The diluted extracts were added to the microtiter plate at 10 μL per sample.
Subsequently, 100 μL of the enzyme conjugate was added and the plate was incubated at
room temperature for one hour. Unbound antigen was removed by washing the wells with
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350 μL of dH2O (6 cycles). After the plate was pat dry, 100 μL of TMB solution was
added and allowed to incubate for 30 minutes at room temperature. Immediately after this,
100 μL of Stop Solution was added to the wells and the plate was read at 450 nm using a
spectrophotometer (using 620 nm as a reference wavelength) and analyzed using the
Magellan software.

5. Intraday Study:
Negative, low, calibrator, and high controls (n=8 per calibrator/control) were
prepared and analyzed on a single day along side the calibration curve. Intraday study
results were averaged and then compared to the results of the calibration curve to
determine intraday precision and accuracy using the following equations:
Relative Standard Deviation (RSD) = SD/xi * 100
Mean Relative Error (MRE) = ((xi – x)/x) * 100
where SD is the standard deviation, xi is the mean of the observed concentration, and x is
the true concentration.

6. Interday Study:
Negative, low, calibrator, and high controls (n=5 per calibrator/control per day)
were prepared and analyzed along side the calibration curve each day over the course of 8
days. The results of the samples were then compared to that of the calibration curve to
determine interday precision, accuracy and assay reproducibility. Used same equations
from intraday study.
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7. Carryover Study:
An aliquot of washed negative hair was spiked with secobarbital at four times the
concentration of the high control to prepare a carryover sample. The calibration curve and
sample were analyzed and carryover was determined by comparing the results of the
negative controls, which were aliquotted before and after the carryover sample.

8. Fortified Hair Preparation:
Negative hair was soaked in a high concentration of secobarbital for several days
to mimic that of authentic, true positive samples. To this end, 1g of negative hair was cut,
washed and then added to a bottle containing one of two solutions. One solution was
made up of deionized water (dH2O) and dimethyl sulfoxide (DMSO) at a 1:1 ratio for a
total of 17mL (Welch et al., 1993).The second solution contained a 1:1 mixture of dH20
and 0.02M HCl in DMSO for a total of 17mL (Welch et al., 2003; Lee et al., 2008).
Secobarbital was spiked into these solutions at 100 times the cutoff value of 500pg/mg.
Everyday the solutions were sonicated for 1 hour and every 3 days a portion of the hair
was removed for analysis. The amount of hair removed from the solution was estimated
to be 30mg of hair so as to analyze the sample in triplicate. The aliquot of hair was
washed using the same protocol as mentioned above except 3mL of each solvent was
used. Additionally, the last wash was saved to be screened alongside the fortified hair
sample. Once the sample was dried down at 65°C, it was weighed and three aliquots of
10mg of hair was prepared. To each, 550μL of HEB was added and incubated for 2 hours
at 75°C. Following incubation, the samples were neutralized, centrifuged, and diluted
according to the same procedure stated above. The previously saved wash was prepared
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similarly after having been divided into three 1mL aliquots and evaporated to dryness
using a gentle stream of nitrogen. 10μL of each sample (three aliquots of extracted hair
and three aliquots of last wash per each condition) was added to the Barbiturate Direct
ELISA Kit plate, along with a calibrator and QCs, and the same ELISA screening
procedure was carried out as mentioned above. This process was repeated until the hair
samples screened positive while the last wash screened negative.

9. Drug Extraction Efficiency Study:
Secobarbital-fortified hair was used to compare the extraction efficiency of an
aqueous extraction (using HEB) to that of a base digestion (using 1M NaOH). Given that
a hair digestion dissolves the hair completely, it represents 100% extraction efficiency.
To this end, 10 mg of fortified hair was subjected to either an aqueous extraction using 1
mL of HEB and incubated for 2hr at 75°C or a base dissolution using 1 mL of 1M NaOH
and incubated for 30min at 75°C, in triplicate. Secobarbital-d5 internal standard (100 μL)
was also added at a concentration of 100 ng/mL. Following incubation, the samples were
neutralized. The samples treated with the aqueous extraction were neutralized using 1
mL of 0.1M phosphate buffer (pH 6.0), whereas the samples digested with the base
solution were neutralized using 300 μL of 20% acetic acid. Calibration curves were
analyzed concurrently with each extraction procedure at concentrations of: 0, 25, 50, 100,
250, 500, 1000, 2000, 5000, and 10000 pg/mg secobarbital. Additionally, quality control
samples contained secobarbital at 100, 500, 1000, and 5000 pg/mg. All samples were
processed using SPE extraction before analysis on the LCMS/MS.
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10. SPE Extraction:
The extracted samples were cleaned up by using mixed mode cation-exchange
solid phase extraction (SPE). These columns were used to allow for the simultaneous
extraction of basic drugs, and the weakly acidic barbiturates through hydrophobic binding.
The columns were conditioned with 1 mL each of methanol and dH2O. After
centrifugation for 10 minutes at 4,200rpm, the sample supernatants were decanted into
the conditioned SPE columns. Here, the samples were gently pushed through the column
bed using a stream of nitrogen. The column beds were then washed with 2 mL of dH2O,
followed by 2 mL of 0.1M acetic acid, and lastly by 2 mL of 25% methanol. Prior to
elution using 1.5mL of a 80:18:2 solution of dichloromethane : isopropyl alcohol :
ammonium hydroxide per sample, the column beds were dried for 14min at 45°C and
with a stream of nitrogen at 50psi. Elutes were completely dried down at 40°C with the
help of a gentle nitrogen stream. Samples were reconstituted in 100 μl of 0.1% formic
acid.

11. LCMS/MS Parameters:
Secobarbital was analyzed using 0.2% acetic acid in water (mobile phase A) and
acetonitrile (mobile phase B). The following gradient was utilized at a flow rate of
0.5mL/min:
Time
0.00
0.00
0.95
1.20
1.21

%B
30
30
30
50
30
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Mass spectral analysis was performed using multiple reaction monitoring (MRM)
with two transitions per analyte (Quantifier/Qualifier). Below are the settings used in
this study
Analyte

Secobarbital
Secobarbital-d5

MRM
Transition

Dwell
Time
(ms)

Frag.
(V)

CE

Gas
Temp
(°C)

Gas
Flow
(L/min)

Neb.
Pressure
(psi)

Cap.
Voltage
(V)

237.1 194.1
237.1 42.1
242.1 199.2
242.1 42.1

30
30
30
30

100
100
100
100

8
8
8
8

350

10

50

4000
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IV. RESULTS:
1. Intraday Study and Limit of Detection (LOD)
Eight aliquots of each of the following different concentrations of secobarbital
was analyzed for the intraday study: 0pg/mg (Negative), 250pg/mg (Low QC), 500pg/mg
(Calibrator), 1000pg/mg (High QC). Figure 2A is a plot of these calibration
concentrations normalized to the negative control using the following equation:
B/B0 × 100
where B is the absorbance value of the bound calibrator and B0 is the absorbance value of
the blank calibrator (Miller, Wylie, & Oliver, 2006). As can be seen from Figure 2A, the
curve is linear with an R² value of 0.986. Figure 2B contains the cumulative data of the
eight replicates for each of the concentrations. The relative standard deviation (RSD) and
the mean relative error (MRE) were well within the acceptable range of 20%.
The theoretical limit of detection was determined to be approximately 90 pg/mg
using the data from Figure 2 and the following equation:
LOD = A0 – (3 × SDneg)
where A0 is the mean absorbance value for the 8 negative samples, and SD is the standard
deviation of the absorbance values (Miller et al., 2006).
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Figure 2 – Intraday results

A)

B)

Figure 2. (A) ELISA dose response curve for secobarbital after intraday study. (B)
The average absorbance obtained from all eight replicates for each concentration
of secobarbital, with their respective SD, RSD, and MRE values.
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2. Interday Study
For the next eight days the same procedure was followed, except the different
concentrations were run in replicates of five instead of eight. The resultant data of the
interday study can be seen in Figure 3. Figure 3A represents a plot of the averages of
each of the points normalized to the negative control, using the same equation used for
the intraday study – B/B0 × 100. The averages of all five readings obtained on all eight
days for each of the calibrator and controls is represented in Figure 3B (n=40). As can be
seen in Figure 3B, both the RSD and MRE were calculated to be well within the
acceptable range of 20%, demonstrating the stability of the assay.
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Figure 3 – Interday Study

A)

B)

Figure 3. (A) ELISA dose response curve for secobarbital after interday study. (B)
The average absorbance obtained from the five replicates for all eight days for
each concentration of secobarbital, with their respective SD, RSD, and MRE
values.
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3. Carryover Study
Using the automated liquid handler, Tecan-fre, a carryover study was performed.
Here, the same negative sample was aliquotted onto the ELISA plate before and after an
aliquot of a highly positive sample (4x the concentration of the high QC) was taken. As
can be seen from Table 1 below, there was approximately a 3% difference between the
absorbance value of the negative sample taken before and after the highly positive sample.

Table 1 – Carryover Study

Table 1. Absorbance values obtained from a negative sample before and after the
addition of a high positive sample onto the ELISA plate by way of an automated
liquid handler.
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4. Fortified Hair –Screening
Following incubation with a high concentration of secobarbital for 6 days, the hair
fortification process was complete. The extracted sample and last wash of the sample was
analyzed by ELISA and the resultant absorbance values can be seen in Table 2B. In
conjunction with Table 2A, it can be seen that the hair, whether soaked in a solution
containing 50% DMSO or 50% 0.02M HCl in DMSO, screened positive for secobarbital
–having average absorbance values of 1.27 and 1.37, respectively, which is lower than
the cutoff absorbance of 1.84. Additionally, the last wash of either condition screened
negative –having absorbance values well above the cutoff.
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Table 2 – Fortified Hair Screening Results

Table 2. (A) ELISA calibration points of secobarbital used to screen for positive
samples. (B) Absorbance values of the secobarbital-fortified hair samples using
the ELISA screen.
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5. Fortified Hair –Confirmation
Known concentrations of secobarbital were analyzed to create a calibration curve
to determine the concentration of secobarbital extracted from the fortified hair samples
(Figure 4A). The fortified hair samples were extracted using both HEB and 1M NaOH to
determine the extraction efficiency of HEB and the resultant data can be seen in Figure
4B. The fortified hair soaked in 50% DMSO (DMSO Fortified Hair) produced 3,243
pg/mg of secobarbital when exposed to HEB, whereas the use of 1M NaOH produced
2,847 pg/mg. In comparison, the hair fortified with 50% 0.02M HCl in DMSO (HCl
Fortified Hair) resulted in a lower concentration of secorbarbital, producing 2,087 pg/mg
of the analyte using HEB and 1,943 pg/mg using 1M NaOH. The %RSD for all is well
below 20%. This demonstrates that, for either condition, HEB does, in fact, successfully
extract secobarbital from fortified hair, resulting in quantities similar to that of the
fortified hair extracted with 1M NaOH.
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Figure 4 – Extraction Efficiency Results

A)

B)

Figure 4. (A) LCMS/MS calibration curve of secobarbital concentrations ranging
from 25-10,000 pg/mg. (B) The average concentration of secobarbital obtained
from the fortified samples using two different extraction solutions.
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V. DISCUSSION:
The validation procedure used for this study was designed to determine if this
type of assay had the capabilities to perform barbiturate screening in hair. Furthermore,
extensive investigations were conducted in order to ensure that the drug extraction was
optimal and that the detection results were reliable and reproducible – a critical
requirement if this assay is applied in situations of routine drug testing. Based on the data
generated in this study, the heterozygous immunoassay can be imployed to differentiate
between the cutoff concentration of secobarbital (500 pg/mg) and its respective low (250
pg/mg) and high (1000 pg/mg) quality controls with using only 10 mg of hair.
Additionally, this distinguishable separation between the concentration points is highly
precise and reproducible, giving an RSD and MRE less than 20% over a course of 8 days
with 5 repeats for each concentration. Although the LOD concentration was derived
theoretically, the resultant value was far less than that of the low control, indicating that
the assay is sensitive enough to distinguish the low control from the LOD and subsequent
background noise. It was also determined that, if an automated liquid handler is to be
used, carryover from a high positive sample to a negative sample is highly improbable,
deeming it an assay fit for high volume throughput.
There are a vast array of methods available in the literature on how to extract
drugs from hair. Because the manufacturer of the ELISA kit used in this study also
provides a hair extraction buffer, it was tested on its efficiency before continual use.
Although both fortification solutions prepared for this study contained DMSO – a reagent
documented to help in the fortifying process by way of carrying the drug into the hair – it
was not known which solution (the one with 0.02M HCl or without) would work for this
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drug class. After 6 days of incubation with an exaggerated amount of secobarbital in
either DMSO solution, a positive result for the ELISA screen was obtained. Three
separate aliquots of fortified hair from each condition resulted in an RSD value less than
10% for both the extracted hair sample and its respective last wash – confidently
solidifying its positivity was due to drug extraction and not removal of external
contamination. The efficiency of the HEB extraction was then tested by comparing it to
that of the 1M NaOH digestion. In concurence with the ELISA results, both fortification
solutions produced hair samples positive for secobarbital. Interestingly, both conditions
resulted in similar, if not, slightly greater quantities of secobarbital when using HEB than
that extracted with 1M NaOH, demonstrating that HEB is an efficient buffer for the
extraction of barbiturates from hair.
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VI. CONCLUSION:
Screening methods for the detection of various drugs in hair have been previously
validated using immunoassays. The intent of this study was to validate a method to
reliably extract and detect barbiturates, specifically secobarbital, in hair to accommodate
the currently prominent need to monitor patients taking potentially abused, prescription
drugs. The study demonstrates that picogram quantities of secobarbital can be extracted
from 10 mg of hair using HEB, with both precision and reproducibility. Additionally, it
was established that, in the event that an automated liquid handler is to be utilized, no
carryover is seen when a negative sample was aliquotted following a very high positive
sample. Ultimately, this method is a good resource for the presumptive detection of
baributrates in hair.
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